Management of hepatitis B
National Institutes of Health · National Institute of Diabetes and Digestive and Kidney Diseases · +3 more institutions
Abstract
Chronic hepatitis B is caused by persistent infection with the hepatitis B virus (HBV), a unique DNA virus that replicates through an RNA intermediate produced from a stable covalently closed circular DNA molecule. Viral persistence appears to be due to inadequate innate and adaptive immune responses. Chronic infection has a variable course after several decades resulting in cirrhosis in up to one-third of patients and liver cancer in a proportion of those with cirrhosis. Sensitive assays for HBV DNA levels in serum have been developed that provide important insights into pathogenesis and natural history. Therapy of hepatitis B is evolving. Peginterferon induces long-term remissions in disease in one-third of…
Citation impact
- FWCI
- 45.36
- Percentile
- 100%
- References
- 203
Authors
5- JHJay H. HoofnagleCorresponding
National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
- EDEdward Doo
NIHR Birmingham Liver Biomedical Research Unit, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
- TJT. Jake Liang
National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
- RFRussell Fleischer
United States Food and Drug Administration
- ASAnna S. Lok
University of Michigan–Ann Arbor
Topics & keywords
- HBeAg
- Hepatology
- Hepatitis B virus
- Hepatitis B
- Medicine
- Cirrhosis
- Immunology
- Nucleoside analogue
- Good health and well-being